Joyce H. S. You
School of Pharmacy
Faculty of Medicine
The Chinese University of Hong Kong
Shatin
NT, Hong Kong
Name/email consistency: high
- Warfarin dosing algorithm using clinical, demographic and pharmacogenetic data from Chinese patients. You, J.H., Wong, R.S., Waye, M.M., Mu, Y., Lim, C.K., Choi, K.C., Cheng, G. J. Thromb. Thrombolysis (2011)
- Pharmacoeconomic evaluation of warfarin pharmacogenomics. You, J.H. Expert. Opin. Pharmacother (2011)
- Uterine artery embolization, hysterectomy, or myomectomy for symptomatic uterine fibroids: a cost-utility analysis. You, J.H., Sahota, D.S., Yuen, P.M. Fertil. Steril. (2009)
- Cost-effectiveness analysis of influenza and pneumococcal vaccination for Hong Kong elderly in long-term care facilities. You, J.H., Wong, W.C., Ip, M., Lee, N.L., Ho, S.C. J. Epidemiol. Community. Health (2009)
- Potential clinical and economic outcomes of CYP2C9 and VKORC1 genotype-guided dosing in patients starting warfarin therapy. You, J.H., Tsui, K.K., Wong, R.S., Cheng, G. Clin. Pharmacol. Ther. (2009)
- Pharmacoeconomics of entecavir treatment for chronic hepatitis B. You, J.H., Chan, F.W. Expert. Opin. Pharmacother (2008)
- Public knowledge, attitudes and behavior on antibiotic use: a telephone survey in Hong Kong. You, J.H., Yau, B., Choi, K.C., Chau, C.T., Huang, Q.R., Lee, S.S. Infection (2008)
- Linezolid versus vancomycin for prosthetic joint infections: a cost analysis. You, J.H., Lee, G.C., So, R.K., Cheung, K.W., Hui, M. Infection (2007)
- Cost-effectiveness of Helicobacter pylori "test and treat" for patients with typical reflux symptoms in a population with a high prevalence of H. pylori infection: a Markov model analysis. You, J.H., Wong, P.L., Wu, J.C. Scand. J. Gastroenterol. (2006)
- The cost-effectiveness of an outreach clinical model in the management and prevention of gonorrhea and chlamydia among Chinese female sex workers in Hong Kong. You, J.H., Wong, W.C., Sin, C.W., Woo, J. Sex. Transm. Dis (2006)
- A cost-utility analysis of hysterectomy, endometrial resection and ablation and medical therapy for menorrhagia. You, J.H., Sahota, D.S., MoYuen, P. Hum. Reprod. (2006)
- Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation?. You, J.H., Chan, F.W., Wong, R.S., Cheng, G. Br. J. Clin. Pharmacol (2005)
- Expectant, medical or surgical treatment for spontaneous abortion in first trimester of pregnancy: a cost analysis. You, J.H., Chung, T.K. Hum. Reprod. (2005)
- The potential clinical and economic outcomes of pharmacogenetics-oriented management of warfarin therapy - a decision analysis. You, J.H., Chan, F.W., Wong, R.S., Cheng, G. Thromb. Haemost. (2004)
- Low-dose or standard-dose proton pump inhibitors for maintenance therapy of gastro-oesophageal reflux disease: a cost-effectiveness analysis. You, J.H., Lee, A.C., Wong, S.C., Chan, F.K. Aliment. Pharmacol. Ther. (2003)
- Arthritis treatment in Hong Kong--cost analysis of celecoxib versus conventional NSAIDS, with or without gastroprotective agents. You, J.H., Lee, K.K., Chan, T.Y., Lau, W.H., Chan, F.K. Aliment. Pharmacol. Ther. (2002)
- Economic analysis of four triple regimens for the treatment of Helicobacter pylori-related peptic ulcer disease in in-patient and out-patient settings in Hong Kong. You, J.H., Lee, K.K., Ho, S.S., Sung, J.J., Kung, N.N., Yung, M., Lee, C., Yee, G.C. Aliment. Pharmacol. Ther. (2001)
- Vancomycin utilization at a teaching hospital in Hong Kong. You, J.H., Lyon, D.J., Lee, B.S., Kwan, S.M., Tang, H.Y. Am. J. Health. Syst. Pharm (2001)
